Barbara Pender
Impact in
- Oncology top 5%
- CAR-T cell therapy research
-
- Immune Cell Function and Interaction
Papers in
- Oncology 6
- CAR-T cell therapy research 6
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- David G. Maloney (8 shared papers)Stanley R. Riddell (4 shared papers)Xueyan Chen (4 shared papers)Cameron J. Turtle (4 shared papers)Laïla‐Aïcha Hanafi (4 shared papers)Shelly Heimfeld (4 shared papers)Colette Chaney (4 shared papers)Sindhu Cherian (4 shared papers)
- Journals
- Blood (3 papers)Journal of Clinical Oncology (2 papers)The Lancet (1 paper)Science Translational Medicine (1 paper)Cancer Immunology Research (1 paper)
- Partner nations
- United States
In The Last Decade
Barbara Pender
8 papers receiving 871 citations
Barbara Pender's Hit Papers
Peers
Comparison fields: 5 of 38
- Oncology 850
- Immunology 213
- Genetics 277
- Biomedical Engineering 242
- Pathology and Forensic Medicine 78
Countries citing papers authored by Barbara Pender
This map shows the geographic impact of Barbara Pender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Pender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Pender more than expected).
Fields of papers citing papers by Barbara Pender
This network shows the impact of papers produced by Barbara Pender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Pender. The network helps show where Barbara Pender may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara Pender, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cells Hit paper breakdown → | 2016 | 741 |
| 2 | 2015 | 59 | |
| 3 | 2015 | 42 | |
| 4 | 2016 | 22 | |
| 5 | 2015 | 13 | |
| 6 | 2015 | 4 | |
| 7 | 2024 | 2 | |
| 8 | 1957 | 1 | |
| 9 | 2007 | 1 |
About Barbara Pender
Barbara Pender is a scholar working on Oncology, Pathology and Forensic Medicine, Immunology, Genetics and Pediatrics, Perinatology and Child Health, having authored 9 papers that have together received 885 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Biosimilars and Bioanalytical Methods (1 paper), Neuroendocrine Tumor Research Advances (1 paper), Genetic and Kidney Cyst Diseases (1 paper), Advancements in Semiconductor Devices and Circuit Design (1 paper) and Integrated Circuits and Semiconductor Failure Analysis (1 paper). The work is most often cited by research in Oncology (850 citations), Immunology (213 citations), Genetics (277 citations), Biomedical Engineering (242 citations) and Pathology and Forensic Medicine (78 citations). Barbara Pender has collaborated with scholars based in United States. Frequent co-authors include David G. Maloney, Stanley R. Riddell, Xueyan Chen, Cameron J. Turtle, Laïla‐Aïcha Hanafi, Shelly Heimfeld, Colette Chaney, Sindhu Cherian, Brent L. Wood and Carolina Berger. Their work appears in journals such as Blood, Journal of Clinical Oncology, The Lancet, Science Translational Medicine and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.